Table 2. In vivo tumor-margin assessment with NIRF.
Lesion No. | Tumor margin determined by | T-margin (in mm) | |
---|---|---|---|
In vivo NIRF | Histopathology | ||
1 | Negative | Negative | 6 |
2 | Negative | Negative | 16 |
3.1 | Negative | Negative | 1.2 |
4 | Negative | Negative | 8 |
5 | Negative | Negative | 4 |
6 | Negative | Negative | 1.7 |
7 | Negative | Negative | 3 |
8.1 | Negative | Positive | <1 |
8.2 | Positive | Positive | <1 |
9 | Positive | Positive | <1 |
10 | Positive | Positive | <1 |
11 | Positive | Positive | <1 |
3.2 | Positive | Positive | 0 |
12 | Positive | Negative* | <1† |
13 | Positive | Negative* | 0† |
14 | Positive | Positive | 0 |
†, assessment of initial resection specimen; *, assessment after additional resection. NIRF, near-infrared fluorescence.